IL155335A0 - Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament - Google Patents

Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament

Info

Publication number: IL155335A0
Authority: IL; Israel
Prior art keywords: medicament; producing; production; same; crystalline monohydrate
Prior art date: 2000-10-12

Application number

IL15533501A

Other languages

English (en)

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-12

Filing date

2001-09-28

Publication date

2003-11-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL155335(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-09-28 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-11-23 Publication of IL155335A0 publication Critical patent/IL155335A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL15533501A 2000-10-12 2001-09-28 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament IL155335A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10050621		2000-10-12
PCT/EP2001/011225 WO2002030928A1 (de)	2000-10-12	2001-09-28	Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (1)

Publication Number	Publication Date
IL155335A0 true IL155335A0 (en)	2003-11-23

Family

ID=7659568

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15533501A IL155335A0 (en)	2000-10-12	2001-09-28	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
IL155335A IL155335A (en)	2000-10-12	2003-04-10	Crystalline monohydrate of tiotropium bromide, method for producing the same and the use thereof in the production of a medicament

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL155335A IL155335A (en)	2000-10-12	2003-04-10	Crystalline monohydrate of tiotropium bromide, method for producing the same and the use thereof in the production of a medicament

Country Status (46)

Country	Link
EP (2)	EP1468998A1 (et)
JP (1)	JP3764422B2 (et)
KR (1)	KR100823860B1 (et)
CN (2)	CN100519558C (et)
AP (1)	AP1572A (et)
AR (2)	AR034389A1 (et)
AT (1)	ATE276253T1 (et)
AU (2)	AU2002214996B2 (et)
BG (1)	BG66161B1 (et)
BR (1)	BR0114584A (et)
CA (1)	CA2425539C (et)
CR (1)	CR6938A (et)
CZ (1)	CZ301841B6 (et)
DE (1)	DE50103666D1 (et)
DK (1)	DK1326862T3 (et)
DZ (1)	DZ3478A1 (et)
EA (1)	EA004381B1 (et)
EC (1)	ECSP034540A (et)
EE (1)	EE04567B1 (et)
EG (1)	EG24142A (et)
ES (1)	ES2228965T3 (et)
GE (1)	GEP20063905B (et)
HR (1)	HRP20030276B1 (et)
HU (1)	HU226830B1 (et)
IL (2)	IL155335A0 (et)
IS (1)	IS2339B (et)
MA (1)	MA25842A1 (et)
ME (2)	ME00243B (et)
MX (1)	MXPA03003221A (et)
MY (1)	MY126931A (et)
NO (1)	NO328465B1 (et)
NZ (1)	NZ525733A (et)
OA (1)	OA12403A (et)
PE (1)	PE20020422A1 (et)
PL (1)	PL207870B1 (et)
PT (1)	PT1326862E (et)
RS (1)	RS50218B (et)
SA (1)	SA01220412B1 (et)
SI (1)	SI1326862T1 (et)
SK (1)	SK287009B6 (et)
TR (1)	TR200402579T4 (et)
TW (1)	TW589313B (et)
UA (1)	UA74215C2 (et)
UY (2)	UY26962A1 (et)
WO (1)	WO2002030928A1 (et)
ZA (1)	ZA200302500B (et)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6608055B2 (en)	2001-06-22	2003-08-19	Boehringer Ingelheim Pharma Kg	Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
RS50441B (sr) *	2001-06-22	2010-03-02	Boehringer Ingelheim Pharma Gmbh. & Co.Kg.	Kristalni antiholinergik, postupak za njegovo pripremanje i njegova primena u proizvodnji leka
DE10212264A1 (de)	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7244415B2 (en)	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
US7311894B2 (en)	2002-03-28	2007-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations containing an anticholinergic
DE10214263A1 (de) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de)	2003-04-16	2004-10-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
PL2083007T3 (pl) *	2003-11-03	2013-09-30	Boehringer Ingelheim Int	Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
ES2342468T3 (es)	2003-11-03	2010-07-07	Boehringer Ingelheim International Gmbh	Procedimiento para la preparacion de sales de tiotropio.
US7968717B2 (en)	2003-11-03	2011-06-28	Boehringer Ingelhein International Gmbh	Crystalline anhydrate with anticholinergic efficacy
HRP20100029T1 (hr) *	2003-11-03	2010-02-28	Boehringer Ingelheim International Gmbh	Novi kristalinični anhidrid s antiholinergičkim učinkom
DE102004016179A1 (de) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Verbindungen zur Behandlung von proliferativen Prozessen
ES2380370T3 (es)	2004-04-22	2012-05-11	Boehringer Ingelheim International Gmbh	Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias
DE102004024454A1 (de)	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE602004020337D1 (de)	2004-08-11	2009-05-14	Boehringer Ingelheim Pharma	Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege
US20060079544A1 (en) *	2004-08-13	2006-04-13	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de)	2004-10-01	2006-04-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
UA95063C2 (ru) *	2004-10-21	2011-07-11	Бёрингер Ингельхайм Интернациональ Гмбх	Блистерная упаковка для применения в ингаляторах
EP1858554A2 (en) *	2005-03-09	2007-11-28	Boehringer Ingelheim International GmbH	New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
EP1877376A1 (de)	2005-04-28	2008-01-16	Boehringer Ingelheim International GmbH	Neue verbindungen zur behandlung von entzündlichen erkrankungen
ES2393794T3 (es)	2005-05-02	2012-12-28	Boehringer Ingelheim International Gmbh	Nuevas formas cristalinas de bromuro de tiotropio
JP2008540367A (ja) *	2005-05-02	2008-11-20	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規結晶性臭化チオトロピウム
NZ564697A (en) *	2005-06-15	2010-04-30	Boehringer Ingelheim Int	Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005030733A1 (de)	2005-07-01	2007-01-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
KR20080039974A (ko) *	2005-08-06	2008-05-07	베링거 인겔하임 인터내셔날 게엠베하	중증 지속성 천식의 치료에서 티오트로퓸 염의 용도
WO2007020227A1 (de)	2005-08-15	2007-02-22	Boehringer Ingelheim International Gmbh	Verfahren zur herstellung von betamimetika
US20070086957A1 (en)	2005-10-10	2007-04-19	Thierry Bouyssou	Combination of medicaments for the treatment of respiratory diseases
US7423146B2 (en)	2005-11-09	2008-09-09	Boehringer Ingelheim International Gmbh	Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de)	2005-12-14	2007-06-21	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Mikronisierung
JP2008530251A (ja) *	2005-12-19	2008-08-07	シコールインコーポレイティド	純粋且つ安定な臭化チオトロピウム
PT1869035E (pt)	2005-12-19	2013-01-10	Sicor Inc	Novas formas de brometo de tiotrópio e processos para sua preparação
JP2009525950A (ja) *	2006-01-04	2009-07-16	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	中等症持続型喘息の治療におけるチオトロピウム塩の使用
EP2060575A1 (de)	2006-04-19	2009-05-20	Boehringer Ingelheim International GmbH	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
EP1847543A1 (de)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US20080051582A1 (en)	2006-07-10	2008-02-28	Sicor Inc.	Process for the preparation of tiotropium bromide
DE502007006951D1 (de)	2006-08-07	2011-05-26	Boehringer Ingelheim Pharma	Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
PE20080610A1 (es)	2006-08-22	2008-07-15	Boehringer Ingelheim Int	Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
EP1923393A1 (en) *	2006-11-17	2008-05-21	Boehringer Ingelheim Pharma GmbH & Co. KG	Crystalline form of tiotropium bromide and urea
EP1925295A1 (de) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Stabile Pulverformulierung enthaltend ein Anticholinergikum
GB0716026D0 (en)	2007-08-16	2007-09-26	Norton Healthcare Ltd	An inhalable medicament
HRP20120334T1 (hr)	2007-10-19	2012-05-31	Boehringer Ingelheim International Gmbh	Supstituirani piperidino-dihidrotienopirimidini
EP2093219A1 (de)	2008-02-22	2009-08-26	Boehringer Ingelheim International Gmbh	Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
US20100272811A1 (en) *	2008-07-23	2010-10-28	Alkermes,Inc.	Complex of trospium and pharmaceutical compositions thereof
EP2379525B1 (en)	2008-12-19	2015-07-29	Boehringer Ingelheim International GmbH	Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
EP2201934A1 (en)	2008-12-23	2010-06-30	CHIESI FARMACEUTICI S.p.A.	Tiotropium aerosol formulation products with improved chemical stability
EP2403851B1 (en)	2009-03-06	2015-06-17	Mahmut Bilgic	New crystalline forms of tiotropium bromide
WO2011015883A1 (en)	2009-08-07	2011-02-10	Generics [Uk] Limited	Dichloromethane solvate of tiotropium bromide and its use
CN102639531B (zh)	2009-08-07	2016-01-20	基因里克斯(英国)有限公司	噻托溴铵的无水合物
EP2513086B1 (en)	2009-12-17	2015-04-29	Boehringer Ingelheim International GmbH	Novel antagonists for ccr2 and uses thereof
PE20121614A1 (es)	2009-12-17	2012-12-21	Boehringer Ingelheim Int	Derivados de 6-amino,4-carbonil-pirimidina sustituida como antagonistas del receptor ccr2
BR112012018865A2 (pt)	2010-01-29	2016-04-12	Boehringer Ingelheim Int	naftiridinas substituídas e seu uso como inibidores de quinase syk
JP2013526507A (ja)	2010-05-12	2013-06-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用
WO2011141477A1 (en)	2010-05-12	2011-11-17	Boehringer Ingelheim International Gmbh	New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP5647339B2 (ja)	2010-05-17	2014-12-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｃｒ２アンタゴニスト及びこれらの使用
JP5636094B2 (ja)	2010-05-25	2014-12-03	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｃｒ２受容体アンタゴニスト
WO2011151251A1 (en)	2010-06-01	2011-12-08	Boehringer Ingelheim International Gmbh	New ccr2 antagonists
EP2668177B1 (en)	2011-01-28	2014-10-22	Boehringer Ingelheim International GmbH	Substituted pyridinyl-pyrimidines and their use as medicaments
TR201102068A2 (tr) *	2011-03-03	2012-09-21	Bi̇lgi̇ç Mahmut	Tiotropyum bromür içeren kristal maddeler
EP2721025B1 (en)	2011-06-16	2015-11-25	Boehringer Ingelheim International Gmbh	New selective ccr2 antagonists
WO2013010839A1 (en)	2011-07-15	2013-01-24	Boehringer Ingelheim International Gmbh	Novel and selective ccr2 antagonists
EA024845B1 (ru)	2011-07-26	2016-10-31	Бёрингер Ингельхайм Интернациональ Гмбх	Замещенные хинолины и их применение в качестве лекарственных средств
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs)	2011-11-28	2014-04-02	Zentiva, K.S.	Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en)	2011-12-19	2012-02-29	Teva Branded Pharmaceutical Prod R & D Inc	An inhalable medicament
US9096579B2 (en)	2012-04-20	2015-08-04	Boehringer Ingelheim International Gmbh	Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
CN104797579A (zh)	2012-11-05	2015-07-22	赞蒂瓦有限合伙公司	噻托溴铵溶剂化物的稳定化
EP2913332A1 (en) *	2014-02-27	2015-09-02	Euticals S.P.A.	Crystalline form of tiotropium bromide with lactose
MY185837A (en)	2014-03-19	2021-06-12	Boehringer Ingelheim Int	Heteroaryl syk inhibitors
US10034866B2 (en)	2014-06-19	2018-07-31	Teva Branded Pharmaceutical Products R&D, Inc.	Inhalable medicament comprising tiotropium
RU2567539C1 (ru) *	2015-02-04	2015-11-10	Индивидуальный предприниматель Михайлов Олег Ростиславович	КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
EP3414243A1 (en)	2016-02-11	2018-12-19	Sima Patent Ve Lisanslama Hizmetleri Ltd. STI	Crystalline form of tiotropium bromide anhydrate
WO2018084817A2 (en) *	2016-11-04	2018-05-11	Si̇ma Patent Ve Li̇sanslama Hi̇zmetleri̇ Ltd. Şti̇	A new form of active agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (de) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
RO117414B1 (ro) *	1992-12-09	2002-03-29	Jager Paul D Waterbury	Compozitie farmaceutica de aerosol in solutie
DE19834506A1 (de) *	1998-07-31	2000-02-03	Hexal Ag	Transmucosales therapeutisches System zur Anwendung von Sildenafil
US6475467B1 (en) *	1998-08-04	2002-11-05	Jago Research Ag	Medicinal aerosol formulations

2001
- 2001-09-28 EP EP04016877A patent/EP1468998A1/de not_active Withdrawn
- 2001-09-28 AP APAP/P/2003/002775A patent/AP1572A/en active
- 2001-09-28 IL IL15533501A patent/IL155335A0/xx active IP Right Grant
- 2001-09-28 CA CA002425539A patent/CA2425539C/en not_active Expired - Lifetime
- 2001-09-28 ME MEP-2008-400A patent/ME00243B/me unknown
- 2001-09-28 CN CNB2005100977370A patent/CN100519558C/zh not_active Ceased
- 2001-09-28 CN CNB018171435A patent/CN1221549C/zh not_active Ceased
- 2001-09-28 DE DE50103666T patent/DE50103666D1/de not_active Expired - Lifetime
- 2001-09-28 DZ DZ013478A patent/DZ3478A1/fr active
- 2001-09-28 HR HR20030276A patent/HRP20030276B1/xx not_active IP Right Cessation
- 2001-09-28 GE GE5214A patent/GEP20063905B/en unknown
- 2001-09-28 TR TR2004/02579T patent/TR200402579T4/xx unknown
- 2001-09-28 EP EP01983510A patent/EP1326862B1/de not_active Expired - Lifetime
- 2001-09-28 DK DK01983510T patent/DK1326862T3/da active
- 2001-09-28 AU AU2002214996A patent/AU2002214996B2/en not_active Expired
- 2001-09-28 UA UA2003054185A patent/UA74215C2/uk unknown
- 2001-09-28 PL PL366041A patent/PL207870B1/pl unknown
- 2001-09-28 NZ NZ525733A patent/NZ525733A/en not_active IP Right Cessation
- 2001-09-28 AU AU1499602A patent/AU1499602A/xx active Pending
- 2001-09-28 SK SK436-2003A patent/SK287009B6/sk not_active IP Right Cessation
- 2001-09-28 PT PT01983510T patent/PT1326862E/pt unknown
- 2001-09-28 OA OA1200300107A patent/OA12403A/fr unknown
- 2001-09-28 AT AT01983510T patent/ATE276253T1/de active
- 2001-09-28 MX MXPA03003221A patent/MXPA03003221A/es active IP Right Grant
- 2001-09-28 RS YU27303A patent/RS50218B/sr unknown
- 2001-09-28 HU HU0301022A patent/HU226830B1/hu unknown
- 2001-09-28 ME MEP-400/08A patent/MEP40008A/xx unknown
- 2001-09-28 EE EEP200300171A patent/EE04567B1/et unknown
- 2001-09-28 SI SI200130219T patent/SI1326862T1/xx unknown
- 2001-09-28 JP JP2002534314A patent/JP3764422B2/ja not_active Expired - Lifetime
- 2001-09-28 CZ CZ20031025A patent/CZ301841B6/cs not_active IP Right Cessation
- 2001-09-28 ES ES01983510T patent/ES2228965T3/es not_active Expired - Lifetime
- 2001-09-28 BR BR0114584-3A patent/BR0114584A/pt not_active Application Discontinuation
- 2001-09-28 KR KR1020037005083A patent/KR100823860B1/ko not_active Expired - Lifetime
- 2001-09-28 WO PCT/EP2001/011225 patent/WO2002030928A1/de not_active Ceased
- 2001-09-28 EA EA200300457A patent/EA004381B1/ru not_active IP Right Cessation
- 2001-10-02 SA SA01220412A patent/SA01220412B1/ar unknown
- 2001-10-09 EG EG20011058A patent/EG24142A/xx active
- 2001-10-09 TW TW090124963A patent/TW589313B/zh active
- 2001-10-10 PE PE2001001000A patent/PE20020422A1/es active IP Right Grant
- 2001-10-10 UY UY26962A patent/UY26962A1/es not_active Application Discontinuation
- 2001-10-10 MY MYPI20014705A patent/MY126931A/en unknown
- 2001-10-12 AR ARP010104782A patent/AR034389A1/es active IP Right Grant
2003
- 2003-03-26 CR CR6938A patent/CR6938A/es unknown
- 2003-03-28 BG BG107687A patent/BG66161B1/bg unknown
- 2003-03-31 ZA ZA200302500A patent/ZA200302500B/en unknown
- 2003-04-07 EC EC2003004540A patent/ECSP034540A/es unknown
- 2003-04-08 MA MA27102A patent/MA25842A1/fr unknown
- 2003-04-09 IS IS6772A patent/IS2339B/is unknown
- 2003-04-10 IL IL155335A patent/IL155335A/en unknown
- 2003-04-11 NO NO20031694A patent/NO328465B1/no not_active IP Right Cessation
2008
- 2008-09-19 AR ARP080104109A patent/AR068527A2/es unknown
2013
- 2013-07-11 UY UY34901A patent/UY34901A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
YU27303A (sh)	2006-05-25
OA12403A (en)	2006-04-18
CA2425539A1 (en)	2003-04-11
DZ3478A1 (fr)	2002-04-18
NO20031694L (no)	2003-04-11
SK4362003A3 (en)	2003-08-05
BR0114584A (pt)	2003-08-26
SI1326862T1 (sl)	2005-02-28
CN1733761A (zh)	2006-02-15
ME00243B (me)	2011-05-10
PL366041A1 (en)	2005-01-24
CN100519558C (zh)	2009-07-29
AP2003002775A0 (en)	2003-03-31
IS2339B (is)	2008-02-15
EP1326862B1 (de)	2004-09-15
AP1572A (en)	2006-02-13
ECSP034540A (es)	2003-07-25
MY126931A (en)	2006-10-31
HUP0301022A2 (hu)	2003-10-28
PL207870B1 (pl)	2011-02-28
HRP20030276B1 (en)	2006-02-28
TW589313B (en)	2004-06-01
DE50103666D1 (de)	2004-10-21
UY34901A (es)	2015-02-27
MEP40008A (en)	2011-02-10
BG66161B1 (bg)	2011-09-30
EP1468998A1 (de)	2004-10-20
JP2004526668A (ja)	2004-09-02
SK287009B6 (sk)	2009-09-07
PE20020422A1 (es)	2002-06-28
JP3764422B2 (ja)	2006-04-05
WO2002030928A1 (de)	2002-04-18
BG107687A (bg)	2003-09-30
CR6938A (es)	2004-10-28
IL155335A (en)	2009-02-11
CN1469877A (zh)	2004-01-21
PT1326862E (pt)	2004-11-30
NZ525733A (en)	2005-01-28
HK1086557A1 (zh)	2006-09-22
AR068527A2 (es)	2009-11-18
DK1326862T3 (da)	2004-11-22
IS6772A (is)	2003-04-09
HU226830B1 (en)	2009-11-30
SA01220412B1 (ar)	2006-11-05
EA004381B1 (ru)	2004-04-29
AU1499602A (en)	2002-04-22
CN1221549C (zh)	2005-10-05
EE200300171A (et)	2003-06-16
HRP20030276A2 (en)	2005-02-28
CZ301841B6 (cs)	2010-07-07
HUP0301022A3 (en)	2005-12-28
ES2228965T3 (es)	2005-04-16
KR100823860B1 (ko)	2008-04-21
NO328465B1 (no)	2010-02-22
KR20030042008A (ko)	2003-05-27
UA74215C2 (uk)	2005-11-15
MA25842A1 (fr)	2003-07-01
AR034389A1 (es)	2004-02-25
ATE276253T1 (de)	2004-10-15
MXPA03003221A (es)	2004-12-03
EE04567B1 (et)	2005-12-15
ZA200302500B (en)	2004-04-22
CA2425539C (en)	2007-04-03
NO20031694D0 (no)	2003-04-11
TR200402579T4 (tr)	2004-12-21
AU2002214996B2 (en)	2007-03-15
UY26962A1 (es)	2002-06-20
EG24142A (en)	2008-08-06
HK1060567A1 (en)	2004-08-13
EP1326862A1 (de)	2003-07-16
RS50218B (sr)	2009-07-15
EA200300457A1 (ru)	2003-10-30
GEP20063905B (en)	2006-08-25

Publication	Publication Date	Title
IL155335A0 (en)	2003-11-23	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
AU2002214996A1 (en)	2002-06-27	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
IL159238A0 (en)	2004-06-01	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
AU2002345016A1 (en)	2003-06-19	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
IL153273A0 (en)	2003-07-06	Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
AU2001262318A1 (en)	2002-03-07	Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
HUP0105148A3 (en)	2003-01-28	Telmisartan polymorph, method for producing same and its use in the preparation of a medicament
HUP0300327A3 (en)	2004-10-28	Percyquinnin, a process for its production and its use as a pharmaceutical
AU2002213977A1 (en)	2002-04-29	Novel anticholinergics, method for the production thereof and use thereof as medicaments
GB2347938B (en)	2001-07-11	Production method for hydrate and device for producing the same
AU2002255321A2 (en)	2003-07-10	Tablets quickly disintegrating in the oral cavity and process for producing the same
AU2002255321A1 (en)	2003-05-01	Tablets quickly disintegrating in the oral cavity and process for producing the same
TWI345975B (en)	2011-08-01	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
AU2002213975A1 (en)	2002-07-04	Novel anticholinergic agents that can be used as medicaments and method for the production thereof
EP1216621A4 (en)	2004-05-26	SOFT SWEETS AND METHOD FOR THE PRODUCTION THEREOF
PL369889A1 (en)	2005-05-02	Anticholinergic agents, method for producing the same and use thereof as medicaments
TWI318211B (en)	2009-12-11	Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments
AU6222901A (en)	2001-11-12	Cyclipostins, a method for their production and the use of the same
HU0001417D0 (en)	2000-06-28	New pharmaceutically applicable salts, process for their production and medicaments containing them
EP1310503A4 (en)	2005-10-05	PROCESS FOR THE PRODUCTION OF HYDRAZINOMONOSACCHARIDE DERIVATIVES AND THEIR USE
HUP0302989A3 (en)	2007-06-28	Benzamidine derivatives and process for production thereof
AU2795202A (en)	2002-06-18	Klainetin and derivatives thereof, method for their production and the use of the same
ZA200308591B (en)	2004-05-12	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug.
HUP0300266A3 (en)	2003-10-28	1,3,4-oxadiazole derivatives and process for producing the same
HUP0203593A3 (en)	2003-12-29	Amycomycin, a process for its production and its use as a pharmaceutical

Legal Events

Date	Code	Title	Description
2009-12-24	FF	Patent granted
2009-12-24	KB	Patent renewed